The analysis of breast cancer patient data (23) suggests that the expression of ICAM-1 on breast tumor cells is associated with longer relapse-free periods and a higher overall survival of breast cancer patients (Supplementary Figure 1A). Here, ICAM1 is linked to breast cancer.